Ex Vivo CD34+ Selected T-Cell Depleted (TCD) Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease (GVHD) and High Treatment Response

Ex vivo CD34+ selected T-cell depletion (TCD) has been developed as a strategy to reduce the incidence of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Clinical characteristics, treatment responses, and outcomes of patients developing acute (a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Barba, Pere, Hilden, Patrick, Devlin, Sean M, Maloy, Molly, Dierov, Djamilia, Nieves, Jimmy, Garrett, Matthew D., Sogani, Julie, Cho, Christina, Barker, Juliet N, Kernan, Nancy A, Castro-Malaspina, Hugo, Jakubowski, Ann A, Koehne, Guenther, Papadopoulos, Esperanza B, Prockop, Susan, Sauter, Craig, Tamari, Roni, van den Brink, Marcel R.M, Avecilla, Scott T, Meagher, Richard, O’Reilly, Richard J, Goldberg, Jenna D., Young, James W, Giralt, Sergio, Perales, Miguel-Angel, Ponce, Doris M
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398850/
https://ncbi.nlm.nih.gov/pubmed/28017734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.12.633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados